Sign in
  • Home
  • Biz News
  • New Products
  • Cell Therapy
  • Medical Devices
  • Journal Papers
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
Thursday, March 23, 2023
  • Sign in / Join
  • Contact
  • About
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.

CELL TRIBUNE Cell Tribune: Cell and Gene Therapy News and Research

CELL TRIBUNE CELL TRIBUNE
  • Home
  • Biz News
    • U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01 Study
      New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
      Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
      Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
      Sigilon Therapeutics approaches the clinic
  • New Products
    • CAR-T cell therapy benefits limited to few patients because of ‘Insurance Snags’
      Helix BioPharma Corp. announces the signing of a non-binding letter of intent with ProMab Biotechnologies to develop cell based therapies
  • Cell Therapy
    • Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
      Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
      Sigilon Therapeutics approaches the clinic
      MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing
      ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting
  • Medical Devices
    • CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
      Intarcia Therapeutics Secures Additional $206M Financing; Gates Foundation to Invest up to $140M in Grants and Equity
      Bionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia
  • Journal Papers
    • Immunotherapy gel targets lingering tumor cells after surgery
      ‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
      Stem cell biologist at Harvard retracts diabetes breakthrough manuscript published in Cell citing reproducibility issues
      PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
      Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 
Business

Purdue Pharma and Exicure Announce Strategic Research Collaboration Agreement to Discover...

Cell Tribune - December 13, 2016 0
1...678Page 8 of 8
62FollowersFollow

EDITOR PICKS

Celixir’s cell therapy gets green light for heart failure trial

Cell Tribune - January 9, 2018

Servier Appoints MaSTherCell For The Development Of Its CAR-T Cell Therapy Manufacturing Platform

Cell Tribune - January 24, 2017

ViaCyte Awarded New CIRM Grant to Support Clinical Trial of PEC-Direct Product Candidate for...

Cell Tribune - September 28, 2017

First systematic study of infections after CAR T-cell therapy

Cell Tribune - November 6, 2017
CELL TRIBUNE
CellTribune.com is your one stop source for Cell and Gene Therapy research and business news.
Contact us: CellTribune@gmail.com

EVEN MORE NEWS

U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01...

July 11, 2020

New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing...

July 9, 2020

Sonoma Biotherapeutics launches with $40 million in Series A funding to...

February 7, 2020

POPULAR CATEGORY

  • Cell Therapy42
  • Business30
  • Clinical Trials14
  • Immunotherapy14
  • Pharma8
  • Journal Papers5
  • Gene Therapy5
  • Disclaimer
  • Privacy
  • Advertisement
  • Contact Us
© Copyright 2016-2019, CellTribune.com